Previously treated cases tested for RR-/MDR-TB (%) in Niger
Niger: Previously treated cases tested for RR-/MDR-TB was 33.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Niger, 2009–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Niger is 33.0%, measured in 2024.
That represents a change of down 62.1% on the previous year and up 135.7% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Niger peaked at 94.0% in 2018 and was at its lowest, 3.6%, in 2011.
Niger ranks 158th of 180 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Niger, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 4.8% | — |
| 2010 | 7.0% | +45.8% |
| 2011 | 3.6% | -48.6% |
| 2012 | 6.2% | +72.2% |
| 2013 | 13.0% | +109.7% |
| 2014 | 14.0% | +7.7% |
| 2015 | 76.0% | +442.9% |
| 2016 | 43.0% | -43.4% |
| 2017 | 93.0% | +116.3% |
| 2018 | 94.0% | +1.1% |
| 2019 | 92.0% | -2.1% |
| 2020 | 81.0% | -12.0% |
| 2021 | 91.0% | +12.3% |
| 2022 | 91.0% | +0.0% |
| 2023 | 87.0% | -4.4% |
| 2024 | 33.0% | -62.1% |
Niger compared with similar countries
- Niger's 33.0% is below the median for low income countries, which is 87.0%, 38% of the median. (24 countries reporting)
- Niger's 33.0% is below the median for Sub-Saharan Africa, which is 91.5%, 36% of the median. (46 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Niger changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2015 | +442.9% | 14.0% | 76.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.8% | 4.8% | 4.8% | 1 |
| 2010s | 44.2% | 3.6% | 94.0% | 10 |
| 2020s | 76.6% | 33.0% | 91.0% | 5 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate 2.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0865 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.53 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Niger?
- Previously treated cases tested for rr-/mdr-tb in Niger was 33.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Niger?
- The highest recorded value was 94.0% in 2018.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Niger?
- The lowest recorded value was 3.6% in 2011.
- How does Niger rank for previously treated cases tested for rr-/mdr-tb?
- Niger ranks 158th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Niger?
- Over the last ten years it is up 135.7%. The long-run trend across the full record is volatile.
- Where does this Niger data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).